FDA

Trending/FDA

Senior woman and doctor writing on clipboard in hospital room

New Alzheimer’s drug to be submitted to FDA for approval

Drug company Biogen Inc. intends to pursue regulatory approval from the Food and Drug Administration (FDA) for their experimental Alzheimer's drug, aducanumab, based on new…

Sign up